Cancer Survival
Predicting cancer survival is crucial for personalized treatment planning and improving patient outcomes. Current research heavily emphasizes the development of sophisticated multimodal machine learning models, incorporating genomic data, pathology images, and patient history, often utilizing architectures like transformer networks, convolutional masked autoencoders, and heterogeneous graph networks to improve prediction accuracy and robustness. These advancements aim to overcome challenges like data imbalance and missing information, ultimately leading to more precise survival estimations and potentially informing the development of more effective cancer therapies. The improved accuracy and interpretability of these models hold significant promise for advancing clinical practice and improving patient care.